Associated Papers
Erlotinib therapy for Olmsted syndrome with p.L655P missense mutation in the TRPV3 gene: a case report.
Zhang J et al.
Frontiers in Medicine, 2025
The cumulative effect of compound heterozygous variants in TRPV3 caused Olmsted syndrome.
Mo R et al.
Journal of Dermatological Science, 2024
The Ca2+-Permeable Cation Transient Receptor Potential TRPV3 Channel: An Emerging Pivotal Target for Itch and Skin Diseases.
Wang G et al.
Molecular Pharmacology, 2017
A novel mutation in TRPV3 gene causes atypical familial Olmsted syndrome.
Ni C et al.
Scientific Reports, 2016
Expanding the Phenotypic Spectrum of Olmsted Syndrome.
Wilson NJ et al.
The Journal of Investigative Dermatology, 2015
Olmsted syndrome: clinical, molecular and therapeutic aspects.
Duchatelet S et al.
Orphanet Journal of Rare Diseases, 2015
Olmsted syndrome in an Iranian boy with a new de novo mutation in TRPV3.
Kariminejad A et al.
Clinical and Experimental Dermatology, 2014
Select a paper to view details